title: Critical evaluation of disease stabilization as a measure of activity of systemic therapy: lessons from trials with arms in which patients do not receive active treatment.
authors.affiliation: Institut Curie and Institut National de la Sante et de la Recherche Medicale U900, Paris, France.
authors.forename: Christophe
authors.initials: C
authors.lastname: Le Tourneau
authors.forename: Xavier
authors.initials: X
authors.lastname: Paoletti
authors.forename: Elodie
authors.initials: E
authors.lastname: Coquan
authors.forename: Marie-Paule
authors.initials: MP
authors.lastname: Sablin
authors.forename: Mustapha
authors.initials: M
authors.lastname: Zoubir
authors.forename: Ian F
authors.initials: IF
authors.lastname: Tannock
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D015986:Confounding Factors, Epidemiologic; D018450:Disease Progression; D018572:Disease-Free Survival; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy; D016032:Randomized Controlled Trials as Topic; D012107:Research Design; D016896:Treatment Outcome
chemical_list: D000970:Antineoplastic Agents